Skip to main content

Diabetes: Appropriate Treatment of Hypertension

CBE ID
0546
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Spring 2014
Is Under Review
No
1.3 Measure Description

The percentage of patients who were dispensed a medication for diabetes and hypertension that are receiving an angiotensin-converting -enzyme-inhibitor (ACEI) or angiotensin receptor blocker (ARB) or direct renin inhibitor (DRI) renin-angiotensin-antagonist medication.

    • 1.14 Numerator

      The number of patients who receive an ACEI or ARB or DRI or ACEI/ARB/DRI Combination during the measurement year.

    • 1.15 Denominator

      Patients who were dispensed at least one prescription for an oral hypoglycemic agent, insulin, incretion mimetics, and at least one prescription for an antihypertensive agent during the measurement year.

    • 1.13a Data dictionary not attached
      No
    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Endocrine Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date
    • Risk Adjustment
      No risk adjustment or risk stratification
      Risk adjustment approach
      Off
      Risk adjustment approach
      Off
      Conceptual model for risk adjustment
      Off
      Conceptual model for risk adjustment
      Off